Immune restoration affects 10‐year survival in people living with HIV / AIDS
HIV Medicine · 2023-03 · 24 (3) · 325-334
DOI: 10.1111/hiv.13391 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 25.08.2022. Verfasst von Bogusz Jan Aksak-Wąs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Szczecin, Poland. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, Anti-HIV Agents, HIV Infections, Immune Reconstitution. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Introduction
In recent years, a reduction in the life expectancy gap between people living with HIV (PLWH) and the general population has been observed, irrespective of CD4 lymphocyte count, due to widespread access to antiretroviral treatment. The increase in the life expectancy of PLWH has increased awareness of both the ageing process and gender discrepancies in immune restoration and survival. Materials and Methods Longitudinal data were collected for 2240 patients followed up at the Hospital for Infectious Diseases in Warsaw, Poland ( n = 1482), and the Department of Acquired Immunodeficiency, Pomeranian Medical University, Szczecin, Poland ( n = 758). Immune restoration was measured from the time of starting combination antiretroviral therapy until achieving 500 CD4 lymphocytes/μL, 800 CD4 lymphocytes/μL, and CD4/CD8 lymphocyte ratios of > 0.8 and > 1.0. Full recovery was achieved when the patient was restored to both 800 CD4 lymphocytes/μL and a CD4/CD8 lymphocyte ratio > 1.0.
Results
For all endpoints, immune restoration had a protective effect by reducing mortality. Patients who achieved immune restoration had a greater chance of reduced mortality than those who did not achieve immune restoration: for CD4 count > 500 cells/μL, HR = 5.4 (interquartile range: 3.09–9.41), p < 0.001; for CD4 > 800 cells/μL, HR = 5.37 (2.52–11.43), p < 0.001; for CD4/CD8 ratio > 0.8, HR = 3.16 (1.81–5.51), p < 0.001; for CD4/CD8 ratio > 1.0, HR = 2.67 (1.49–5.24), p = 0.001, and for full immune recovery, HR = 3.62 (1.63–8.04), p = 0.002.
Conclusions
Immune restoration remains a powerful factor in improving the survival of PLWH, regardless of the speed of recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Szczecin, Poland.
- Department of Adults' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
- Hospital for Infectious Diseases in Warsaw, Warsaw, Poland.
- Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Szczecin, Poland.
ORCID-Profile: Bogusz Jan Aksak-Wąs, Justyna D Kowalska, Daniel Chober
Zitieren
APA
Aksak-Wąs, B. J., Kowalska, J. D., Ząbek, P., Serwin, K., Rafalska-Kosior, M., Gołąb, J., Chober, D., Skonieczna-Żydecka, K., Hackiewicz, M., & Parczewski, M. (2023). Immune restoration affects 10‐year survival in people living with HIV / AIDS. HIV Medicine, 24(3), 325-334. https://doi.org/10.1111/hiv.13391
Vancouver
Aksak-Wąs BJ, Kowalska JD, Ząbek P, Serwin K, Rafalska-Kosior M, Gołąb J, et al. Immune restoration affects 10‐year survival in people living with HIV / AIDS. HIV Medicine. 2023;24(3):325-334. doi:10.1111/hiv.13391
BibTeX
@article{AksakWs2023,
author = {Aksak-Wąs, Bogusz Jan and Kowalska, Justyna D and Ząbek, Piotr and Serwin, Karol and Rafalska-Kosior, Milena and Gołąb, Joanna and Chober, Daniel and Skonieczna-Żydecka, Karolina and Hackiewicz, Małgorzata and Parczewski, Miłosz},
title = {Immune restoration affects 10‐year survival in people living with HIV / AIDS},
journal = {HIV Medicine},
year = {2023},
volume = {24},
number = {3},
pages = {325--334},
doi = {10.1111/hiv.13391}
}
EUVIMED